Morari Medical Launches MOR Patch After FDA Clearance

Morari Medical launched the MOR adhesive perineal stimulation patch at CES 2026; the device is FDA-cleared for safety and sells for $299 with immediate availability. The patch, originally developed for premature ejaculation, delivers mild electrical pulses and pairs with a Bluetooth smartphone app that defaults data recording to opt-out. FDA clearance covers safety only; clinical claims for treating sexual dysfunction remain unvalidated.
Scoring Rationale
Official FDA clearance and commercial launch drive impact, but niche sexual-health focus and limited efficacy evidence constrain broader significance.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems